2′-fucosyllactose cas 41263-94-9

Chemical Name: 2′-Fucosyllactose
CAS No.: 41263-94-9
Molecular Fomula: C18H32O15
Molecular weight:488.44
Appearance:White to ivory-coloured spray-dried powder
Assay: 90%

  ... 正在查看此商品

  分享
Guaranteed Safe Checkout

2′-Fucosyllactose (CAS 41263-94-9): Comprehensive User Guide

1. Product Overview & Specifications

2′-Fucosyllactose (2′-FL, CAS 41263-94-9) is a premium human milk oligosaccharide (HMO) widely used in infant nutrition, pharmaceuticals, and biomedical research. Below are its key specifications:

Parameter 2′-Fucosyllactose Competitor A (3-FL) Competitor B (LNT)
CAS Number 41263-94-9 34312-29-7 14116-41-5
Purity ≥98% (HPLC) ≥95%
Solubility Water-soluble Partial solubility Low solubility
Certifications GRAS, EFSA, FDA GRAS N/A

2. Key Applications

Infant Nutrition

2′-FL replicates the bioactive components of human breast milk, enhancing immunity and gut health in infant formula.

Pharmaceuticals

Used in synbiotics, anti-inflammatory drugs, and immune-modulating therapies due to its prebiotic and anti-pathogen properties.

Research

Critical for studying gut microbiota, pathogen inhibition, and metabolic pathways in preclinical models.

3. Usage Scenarios

Infant Formula Production

  1. Assess nutritional requirements per regional regulations.
  2. Select 2′-FL grade (pharmaceutical/food).
  3. Conduct QC tests: HPLC purity, microbial limits.
  4. Blend with other HMOs under GMP conditions.
  5. Perform stability testing (24-month shelf life).
  6. Submit compliance documentation to regulators.

4. Client Success Stories

Case 1: NutriBaby Inc. (USA)

Challenge: Develop EU-compliant hypoallergenic formula.
Solution: 2′-FL integration at 1.2g/L with LNnT.
Result: 35% market share growth in 18 months; EFSA approval secured.

Case 2: PharmaHealth Co. (Germany)

Challenge: Create IBD therapeutic with HMOs.
Solution: 2′-FL/SCFA combination therapy.
Result: 50% reduction in inflammation markers during Phase II trials.

Case 3: BioResearch Labs (Singapore)

Challenge: Study HMO impact on neonatal immunity.
Solution: Custom 2′-FL batches (≥99% purity).
Result: Published in Nature Microbiology; 3 patents filed.

5. Request a Quote

Email: info@vivalr.com
Phone: (86) 15866781826

Submit your project requirements for tailored 2′-FL solutions, including bulk pricing, COAs, and regulatory support.

0.00
0 条评论
5
0
4
0
3
0
2
0
1
0
成为第一个评论 “2′-fucosyllactose cas 41263-94-9”

您的邮箱地址不会被公开。 必填项已用 * 标注

这是必填栏。

这是必填栏。

这是必填栏。

评论

目前还没有评论。

类别 
我的购物车
愿望清单
最近浏览
类别
Wait! before you leave…
Get 30% off for your first order
CODE30OFFCopy to clipboard
Use above code to get 30% off for your first order when checkout
比较产品 (0 产品)